LiverScreen related activities at EASL Congress 2025
The ambition of the LiverScreen Consortium has been realised with the screening of more than 30.000 participants from the general population across 9 different European Countries and the development & validation of the Liver Risk Score, bringing forward significant new & important knowledge to the field of early liver disease detection.
LiverScreen Networking Session at General Hepatology Track Hub
Thursday 8 May, 2025
Time: 16:15-16:45.
Title: The LiverScreen Journey
Speakers: Dr Isabel Graupera and Dr Pere Ginès
ORAL presentation – Late Breaker Abstract:
Saturday, 10 May, 14:00 – 14:15 CEST
LB2553 High prevalence of undiagnosed liver fibrosis in the adult european population driven by metabolic risk factors and alcohol consumption. results from the prospective liverscreen cohort in 30,541 subjects Oral presentation
Presenter: Isabel Graupera
Room: De Groote Room